Boston Scientific BSX has been gaining from product launches and accretive acquisitions. International expansion remains a ...

Digital kiosks have helped Boston Medical Center Health System serve more patients and more easily meet regulatory requirements. The health system started installing iPads for patient check-ins last ...

Bullish option flow detected in Boston Scientific (BSX) with 2,458 calls trading, 1.0x expected, and implied vol increasing almost 2 points to ...

Boston Scientific Corp. closed 4.20% short of its 52-week high of $107.17, which the company achieved on February 5th.

National Science Day celebrated annually on February 28 every year commemorates the anniversary of Sir C.V. Raman’s ground-breaking discovery of the ‘Raman Effect’ in 1928. This discovery earned him ...

The US medical device company will pay up to $540 million for the Rehovot-based intravascular ultrasound device developer for treating high blood pressure. Medical device giant Boston Scientific has ...

The move is set to broaden interventional cardiology therapies with ultrasound-based renal denervation therapy for treating hypertension. Credit: PeopleImages.com – Yuri A / Shutterstock. Boston ...

Ajax Health announced today that, with Boston Scientific and KKR, it formed a new medical technology entity called FlowMod. The new organization comes as a result of a collaboration between the ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ultrasound-based therapy for stubbornly high blood pressure. The acquisition sets up ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a strategic investor in SoniVie, Boston Scientific currently holds an equity ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that has developed the Tivus Intravascular Ultrasound System.